Clinical illness with viable SARS-CoV-2 virus presenting 72 days after infection in an immunocompromised patient. Hughes CM, Gregory GP, Pierce AB, Druce JD, et al. Infect Control Hosp Epidemiol 2021 Mar 19:1-12. doi: 10.1017/ice.2021.

Read + Share

Amedeo Smart

Independent Medical Education

Hughes CM, Gregory GP, Pierce AB, Druce JD, et al. Clinical illness with viable SARS-CoV-2 virus presenting 72 days after infection in an immunocompromised patient. Infect Control Hosp Epidemiol 2021 Mar 19:1-12. doi: 10.1017/ice.2021.
PMID: 33736721